Get started
Edwards Lifesciences CorporationEdwards Lifesciences CorporationEdwards Lifesciences Corporation

Edwards Lifesciences Corporation

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options Bonds

EW chart


Full chart

Key facts today


Edwards Lifesciences gained CE mark approval for its Sapien M3 mitral valve replacement system, targeting patients with symptomatic mitral regurgitation unsuitable for surgery or other therapies.
Analyze the impactAnalyze the impact

EW upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪40.65 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
28.33
Basic EPS (TTM)
2.46 USD
Net income (FY)
‪874.60 M‬ USD
Revenue (FY)
‪5.44 B‬ USD
Shares float
‪574.31 M‬
Beta (1Y)
0.53

Employees


Employees (FY)
‪15.8 K‬
Change (1Y)
‪−4 K‬ −20.20%
Revenue / Employee (1Y)
‪344.27 K‬ USD
Net income / Employee (1Y)
‪88.66 K‬ USD

About Edwards Lifesciences Corporation


Sector
Health Technology
Industry
Medical Specialties
CEO
Bernard J. Zovighian
Website
edwards.com
Headquarters
Irvine
Founded
1958
FIGI
BBG000BRXP69
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

EW news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

EW highest yielding bonds


US28176EAD0
EDWARDS LIFE. 18/28
Yield to maturity
5.18%
Maturity date
Jun 15, 2028

See all EW bonds 


Check out other big names from the same industry as EW.

Frequently Asked Questions


The current price of EW is 69.87 USD — it has increased by 0.40% in the past 24 hours. Watch Edwards Lifesciences Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Edwards Lifesciences Corporation stocks are traded under the ticker EW.
EW stock has risen by 2.50% compared to the previous week, the month change is a 1.83% rise, over the last year Edwards Lifesciences Corporation has showed a −23.03% decrease.
We've gathered analysts' opinions on Edwards Lifesciences Corporation future price: according to them, EW price has a max estimate of 90.00 USD and a min estimate of 61.00 USD. Watch EW chart and read a more detailed Edwards Lifesciences Corporation stock forecast: see what analysts think of Edwards Lifesciences Corporation and suggest that you do with its stocks.
EW reached its all-time high on Dec 30, 2021 with the price of 131.73 USD, and its all-time low was 1.00 USD and was reached on Nov 1, 2000. View more price dynamics on EW chart.
See other stocks reaching their highest and lowest prices.
EW stock is 1.36% volatile and has beta coefficient of 0.53. Track Edwards Lifesciences Corporation stock price on the chart and check out the list of the most volatile stocks — is Edwards Lifesciences Corporation there?
Today Edwards Lifesciences Corporation has the market capitalization of ‪40.93 B‬, it has decreased by −3.99% over the last week.
Yes, you can track Edwards Lifesciences Corporation financials in yearly and quarterly reports right on TradingView.
Edwards Lifesciences Corporation is going to release the next earnings report on Apr 23, 2025. Keep track of upcoming events with our Earnings Calendar.
EW earnings for the last quarter are 0.59 USD per share, whereas the estimation was 0.55 USD resulting in a 7.13% surprise. The estimated earnings for the next quarter are 0.60 USD per share. See more details about Edwards Lifesciences Corporation earnings.
Edwards Lifesciences Corporation revenue for the last quarter amounts to ‪1.39 B‬ USD, despite the estimated figure of ‪1.36 B‬ USD. In the next quarter, revenue is expected to reach ‪1.40 B‬ USD.
EW net income for the last quarter is ‪385.60 M‬ USD, while the quarter before that showed ‪363.50 M‬ USD of net income which accounts for 6.08% change. Track more Edwards Lifesciences Corporation financial stats to get the full picture.
No, EW doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 15, 2025, the company has ‪15.8 K‬ employees. See our rating of the largest employees — is Edwards Lifesciences Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Edwards Lifesciences Corporation EBITDA is ‪1.68 B‬ USD, and current EBITDA margin is 29.41%. See more stats in Edwards Lifesciences Corporation financial statements.
Like other stocks, EW shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Edwards Lifesciences Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Edwards Lifesciences Corporation technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Edwards Lifesciences Corporation stock shows the sell signal. See more of Edwards Lifesciences Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.